High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis : a multi-arm, multi-stage randomised controlled trial
- Submitting institution
-
University of St Andrews
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 251882192
- Type
- D - Journal article
- DOI
-
10.1016/S1473-3099(16)30274-2
- Title of journal
- Lancet Infectious Diseases
- Article number
- -
- First page
- 39
- Volume
- 17
- Issue
- 1
- ISSN
- 1473-3099
- Open access status
- Compliant
- Month of publication
- October
- Year of publication
- 2016
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
28
- Research group(s)
-
B - Infection and Global Health
- Citation count
- 157
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- The author made a substantial contribution to the conception and design of the study and to analysis and interpretation of study data. The author helped draft the output and critique the output for important intellectual content.
- Non-English
- No
- English abstract
- -
